Pharmacological treatment of pre-eclampsia and eclampsia

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: MORGADO, Manuel (University of Beira Interior, Health Science Faculty, Covilhã, Portugal)
  • Co-author(s): Gonçalo Peres: Health Science Faculty, University of Beira Interior, Covilhã, Portugal
    Elisa Cairrão: Health Science Faculty, University of Beira Interior, Covilhã, Portugal;Health Sciences Research Centre, CICS-UBI, University of Beira Interior, Covilhã, Portugal
    Ema Paulino: Portuguese Pharmaceutical Society, Lisbon, Portugal
    Manuel Morgado: Health Science Faculty, University of Beira Interior, Covilhã, Portugal;Pharmaceutical Services, Hospital Centre of Cova da Beira, Covilhã, Portugal;Health Sciences Research Centre, CICS-UBI, University of Beira Interior, Covilhã, Portugal
  • Abstract:

    Background

    Pre-eclampsia and eclampsia are two hypertensive disorders of pregnancy, recognised as major causes of maternal and perinatal death worldwide. Pharmacological prevention measures are limited to low dose aspirin. It is of vital importance that the current therapies for these diseases are as effective and safe as possible.

    Purpose

    To review..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login